Evidence map›Paper›PMID 42460990›Full record

ReviewFEMS microbiology reviews2026

Organosulfur scaffolds as quorum sensing and biofilm modulators in Gram-negative bacteria.

David C Nwobodo, Melford C Egbujor, Sammy Kiprotich, Michael M Meijler

Abstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David C NwobodoDepartment of Chemistry, Ben-Gurion University of the Negev, Be'er Sheva, 8410501, Israel.
Melford C EgbujorDepartment of Chemistry, Federal University Otuoke, Bayelsa State, 562103, Nigeria.
Sammy KiprotichDepartment of Chemistry, Ben-Gurion University of the Negev, Be'er Sheva, 8410501, Israel.
Michael M MeijlerDepartment of Chemistry, Ben-Gurion University of the Negev, Be'er Sheva, 8410501, Israel.ORCID 0000-0001-7095-1467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quorum sensing (QS) is a cell-density-dependent communication system that coordinates bacterial virulence, biofilm formation, motility, and stress adaptation, making it a compelling target for antivirulence intervention. Due to the possibility of sulfonyl (-SO₂-) and sulfinyl (-S = O-) functional groups to impart specific electronic and steric properties that can modulate bacterial signaling and receptor interactions, organosulfur compounds are increasingly gaining attention. This review highlights recent advances in the development of sulfonyl- and sulfinyl-containing organosulfur compounds as modulators of QS and biofilm formation in clinically relevant Gram-negative pathogens. Both natural and synthetic quorum-sensing inhibitors are considered, with activity directed toward LuxR-type regulators, diffusible signal factor (DSF)-mediated systems, and the Las/Rhl networks of Gram-negative bacteria, including Pseudomonas aeruginosa, Vibrio spp., Chromobacterium violaceum, and Xylella fastidiosa. Emphasis is placed on emerging structure-activity relationships and mechanistic insights derived from biochemical and computational studies. Key challenges, including resistance potential, pharmacological constraints, and delivery considerations, are also discussed. Together, we provide an integrated microbiological and medicinal chemistry perspective for the rational development of organosulfur-based strategies to attenuate QS-regulated pathogenicity.

Indexed as

Anti-Bacterial AgentsBiofilmsGram-Negative BacteriaQuorum SensingSulfur CompoundsStructure-Activity RelationshipAnti-Bacterial AgentsSulfur Compoundsantibiotic resistanceantivirulencebiofilmorganosulfurquorum sensingsulfonamides

Identifiers

PMID42460990
PMCPMC13411267

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.